Cas:371978-45-9 1H-imidazo[1,5-b]indazole manufacturer & supplier

We serve Chemical Name:1H-imidazo[1,5-b]indazole CAS:371978-45-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1H-imidazo[1,5-b]indazole

Chemical Name:1H-imidazo[1,5-b]indazole
CAS.NO:371978-45-9
Synonyms:1H-Imidazo[1,5-b]indazole(9CI)
Molecular Formula:C9H7N3
Molecular Weight:157.17200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:30.18000
Exact Mass:157.06400
LogP:0.86190

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1H-Imidazo[1,5-b]indazole(9CI) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Imidazo[1,5-b]indazole(9CI) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Imidazo[1,5-b]indazole(9CI) Use and application,1H-Imidazo[1,5-b]indazole(9CI) technical grade,usp/ep/jp grade.


Related News: Patients given the vaccine also experienced a reduction in cerebrospinal fluid biomarkers of abnormal tau, results show. 1H-imidazo[1,5-b]indazole manufacturer Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release. 1H-imidazo[1,5-b]indazole supplier Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release. 1H-imidazo[1,5-b]indazole vendor Vietnam backtracked on Saturday and narrowed its restrictions to most flights from mainland China. 1H-imidazo[1,5-b]indazole factory The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. Gerald Masoudi, the Covington partner who handled the recent inquiry for Lilly, once served as the FDA’s chief counsel. Masoudi did not respond to requests for comment.